High Grade Urothelial Carcinoma Not Yet Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0153452 (High Grade Urothelial Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05656235Renal Retention in High Grade Upper Tract Urothelial CancerTreatment